January 9, 2025 - 03:54

Recent minutes from the Federal Reserve's December meeting indicate a shift in the central bank's stance regarding interest rates and inflation. Officials expressed concerns that achieving the targeted 2% inflation rate may take longer than previously expected. They highlighted potential risks stemming from trade and immigration policies that could impact economic stability.
In light of these factors, Fed officials are leaning towards maintaining higher interest rates for an extended period. This approach suggests a possible slowdown in the pace of rate cuts if inflation remains elevated. The discussions reflect a growing awareness of the complexities surrounding current economic conditions and the challenges in managing inflation effectively.
Additionally, tensions have surfaced between the Federal Reserve and the incoming administration, particularly with President-elect Donald Trump and Fed Chair Jerome Powell regarding interest rate policies. As the economic landscape evolves, the Fed's cautious strategy underscores its commitment to navigating these challenges while aiming for sustainable growth.
June 7, 2026 - 04:43
Why Pay More for Gold? GLDM Offers the Same Bullion for a Fraction of GLD's CostA 58-year-old investor with $100,000 parked in SPDR Gold Trust (GLD) as a crisis hedge is paying roughly $300 more per year than necessary for the exact same bars of bullion. That is the...
June 6, 2026 - 00:01
The Spill: Why Financial Pros Are Piling Into IWM Right NowAfter years of playing second fiddle to mega-cap tech stocks, small-cap equities are suddenly the center of attention. The iShares Russell 2000 ETF, known by its ticker IWM, is seeing a wave of...
June 5, 2026 - 04:07
Medallion Financial Corp. Exposes ZimCal’s Latest Campaign of Distortion and the Risks of Electing Its Unqualified NomineesMedallion Financial Corp. has issued a sharp rebuttal against ZimCal`s latest proxy fight, accusing the investment firm of running a campaign built on distortions and misaligned incentives. The...
June 4, 2026 - 04:31
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration DocumentOSE Immunotherapeutics SA announced its audited consolidated financial results for the full year 2025 on June 3, 2026. The company confirmed that the audited figures are consistent with the...